Reuters logo
BRIEF-Sun Pharma may have single digit decline in consol revenue for FY 18 vs FY 17 - exec
May 26, 2017 / 1:36 PM / 4 months ago

BRIEF-Sun Pharma may have single digit decline in consol revenue for FY 18 vs FY 17 - exec

May 26 (Reuters) - Sun Pharmaceutical Industries Ltd

* Dilip Shanghvi says may have single digit decline in consol revenue for FY 18 versus FY 17

* Dilip Shanghvi says “FY18 is likely to be a challenging year for us”

* Dilip Shanghvi says co took $45 million u.s. Inventory related charge in Q4 that is unlikely to be recurring

* Dilip Shanghvi says co awaiting FDA inspection on Halol, unaware of FDA’s stance on the facility

* Dilip Shanghvi says value of first-to-file products even during exclusivity is likely to go down Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below